Zurich Cantonal Bank’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$91.8M Buy
1,513,317
+48,032
+3% +$2.8M 0.2% 93
2025
Q4
$79M Sell
1,465,285
-99,271
-6% -$4.78M 0.17% 112
2025
Q3
$70.6M Sell
1,564,556
-38,626
-2% -$1.8M 0.16% 111
2025
Q2
$74.2M Buy
1,603,182
+155,550
+11% +$7.64M 0.18% 101
2025
Q1
$88.3M Buy
1,447,632
+33,983
+2% +$1.98M 0.25% 68
2024
Q4
$80M Buy
1,413,649
+20,658
+1% +$1.15M 0.23% 78
2024
Q3
$72.1M Sell
1,392,991
-37,826
-3% -$1.77M 0.21% 81
2024
Q2
$59.4M Buy
1,430,817
+530,113
+59% +$23.7M 0.19% 88
2024
Q1
$48.8M Sell
900,704
-11,355
-1% -$578K 0.17% 107
2023
Q4
$46.8M Sell
912,059
-226,406
-20% -$11.9M 0.18% 106
2023
Q3
$66.1M Sell
1,138,465
-67,943
-6% -$4.16M 0.29% 67
2023
Q2
$77.1M Buy
1,206,408
+12,211
+1% +$819K 0.34% 57
2023
Q1
$82.8M Buy
1,194,197
+125,204
+12% +$8.83M 0.4% 49
2022
Q4
$76.9M Buy
1,068,993
+17,557
+2% +$1.32M 0.41% 47
2022
Q3
$74.7M Buy
1,051,436
+21,281
+2% +$1.54M 0.44% 45
2022
Q2
$79.3M Sell
1,030,155
-73,993
-7% -$5.64M 0.46% 42
2022
Q1
$80.6M Buy
1,104,148
+132,341
+14% +$8.89M 0.4% 44
2021
Q4
$60.6M Sell
971,807
-141,867
-13% -$8.32M 0.29% 64
2021
Q3
$65.9M Sell
1,113,674
-36,796
-3% -$2.42M 0.36% 57
2021
Q2
$76.9M Buy
1,150,470
+55,675
+5% +$3.63M 0.43% 40
2021
Q1
$69.1M Buy
1,094,795
+191,148
+21% +$11.9M 0.41% 46
2020
Q4
$56.1M Sell
903,647
-15,820
-2% -$973K 0.34% 59
2020
Q3
$55.4M Buy
919,467
+122,813
+15% +$7.39M 0.39% 49
2020
Q2
$46.8M Sell
796,654
-202,531
-20% -$12.1M 0.4% 44
2020
Q1
$55.7M Buy
999,185
+252,961
+34% +$15.5M 0.52% 32
2019
Q4
$47.9M Buy
746,224
+363,278
+95% +$20.8M 0.37% 45
2019
Q3
$19.4M Sell
382,946
-4,003
-1% -$188K 0.16% 135
2019
Q2
$17.5M Sell
386,949
-147,852
-28% -$6.89M 0.15% 143
2019
Q1
$25.5M Buy
534,801
+166,852
+45% +$8.31M 0.23% 96
2018
Q4
$19.1M Sell
367,949
-976
-0.3% -$52.4K 0.19% 121
2018
Q3
$22.9M Sell
368,925
-5,371
-1% -$319K 0.19% 127
2018
Q2
$20.7M Sell
374,296
-12,738
-3% -$688K 0.18% 127
2018
Q1
$24.5M Buy
387,034
+23,470
+6% +$1.51M 0.22% 97
2017
Q4
$22.3M Sell
363,564
-2,629
-0.7% -$164K 0.2% 112
2017
Q3
$23.3M Buy
366,193
+18,748
+5% +$1.09M 0.22% 105
2017
Q2
$19.4M Sell
347,445
-4,715
-1% -$257K 0.19% 122
2017
Q1
$19.1M Sell
352,160
-147,716
-30% -$8.1M 0.19% 131
2016
Q4
$29.2M Sell
499,876
-192,576
-28% -$10.5M 0.3% 74
2016
Q3
$37.3M Sell
692,452
-167,022
-19% -$10.7M 0.39% 56
2016
Q2
$63.2M Buy
859,474
+165,497
+24% +$11.7M 0.82% 17
2016
Q1
$44.3M Buy
693,977
+18,138
+3% +$1.14M 0.56% 36
2015
Q4
$46.5M Buy
675,839
+130,694
+24% +$8.64M 0.59% 34
2015
Q3
$32.3M Buy
545,145
+99,162
+22% +$6.29M 0.46% 47
2015
Q2
$29.7M Sell
445,983
-11,491
-3% -$757K 0.41% 59
2015
Q1
$29.5M Buy
457,474
+283,630
+163% +$17.8M 0.41% 62
2014
Q4
$10.3M Buy
173,844
+27,498
+19% +$1.55M 0.31% 62
2014
Q3
$7.49M Sell
146,346
-56,051
-28% -$2.8M 0.25% 88
2014
Q2
$9.82M Sell
202,397
-29,002
-13% -$1.43M 0.29% 80
2014
Q1
$12M Buy
231,399
+24,377
+12% +$1.3M 0.37% 54
2013
Q4
$11M Sell
207,022
-721
-0.3% -$36.7K 0.36% 60
2013
Q3
$9.61M Buy
207,743
+34,600
+20% +$1.52M 0.33% 64
2013
Q2
$7.74M Buy
+173,143
New +$7.52M 0.27% 88

Other funds holding BMY

Zurich Cantonal Bank's BMY Position: Q1 2026 in Review

Zurich Cantonal Bank increased its Bristol-Myers Squibb (BMY) stake by 3.3% in Q1 2026, buying an estimated $2.8M and bringing the position to 1,513,317 shares worth $91.8M. The position accounts for 0.2% of the portfolio, ranked #93.

Zurich Cantonal Bank first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Zurich Cantonal Bank held 1,513,317 shares of Bristol-Myers Squibb worth $91.8M as of Q1 2026.
  • Zurich Cantonal Bank bought 48,032 Bristol-Myers Squibb shares in Q1 2026, an estimated $2.8M.
  • Bristol-Myers Squibb made up 0.2% of Zurich Cantonal Bank's portfolio in Q1 2026, its #93 holding.
  • Zurich Cantonal Bank first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.